Member of the Association of American Physicians
Michael Camilleri mainly focuses on Internal medicine, Gastroenterology, Irritable bowel syndrome, Gastric emptying and Constipation. The concepts of his Internal medicine study are interwoven with issues in Placebo and Endocrinology. His Gastroenterology research is multidisciplinary, incorporating perspectives in Pathophysiology and Motility.
His biological study spans a wide range of topics, including Inflammation, Immunology and Psychosocial. His Gastric emptying study combines topics in areas such as Diabetes mellitus, Breath test and Nuclear medicine, Scintigraphy. His studies in Constipation integrate themes in fields like Pelvic floor and Defecation.
His primary areas of study are Internal medicine, Gastroenterology, Irritable bowel syndrome, Gastric emptying and Endocrinology. Much of his study explores Internal medicine relationship to Placebo. His study in Placebo is interdisciplinary in nature, drawing from both Anesthesia and Randomized controlled trial.
His study focuses on the intersection of Gastroenterology and fields such as Nausea with connections in the field of Vomiting. His studies deal with areas such as Disease, Pharmacology, Bioinformatics and Intensive care medicine as well as Irritable bowel syndrome. His Gastric emptying research integrates issues from Breath test, Weight loss, Diabetes mellitus and Nuclear medicine, Scintigraphy.
His main research concerns Internal medicine, Gastroenterology, Gastric emptying, Irritable bowel syndrome and In patient. His Internal medicine research focuses on subjects like Placebo, which are linked to Adverse effect. Michael Camilleri has researched Gastroenterology in several fields, including Feces, Excretion and Esophagogastroduodenoscopy.
His work deals with themes such as Diabetes mellitus, Postprandial, Obesity and Nausea, which intersect with Gastric emptying. His research integrates issues of Abdominal pain and Disease in his study of Irritable bowel syndrome. Michael Camilleri interconnects Bloating, Dyssynergia and Intensive care medicine in the investigation of issues within Constipation.
Internal medicine, Gastroenterology, Gastric emptying, Irritable bowel syndrome and Gastroparesis are his primary areas of study. His research on Internal medicine often connects related topics like Placebo. His study in the fields of Bloating under the domain of Gastroenterology overlaps with other disciplines such as In patient.
His Gastric emptying research includes elements of Obesity, Weight loss, Diabetes mellitus, Postprandial and Hormone. The various areas that Michael Camilleri examines in his Irritable bowel syndrome study include FGF19, Disease, Multi omics, Abdominal pain and Computational biology. His Gastroparesis research includes themes of Cisapride, Cronbach's alpha, Pylorus, Scintigraphy and Biomarker.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis
Rohan Khera;Mohammad Hassan Murad;Apoorva K. Chandar;Parambir S. Dulai.
JAMA (2016)
Functional gastroduodenal disorders
Jan Tack;Nicholas J. Talley;Michael Camilleri;Gerald Holtmann.
Gastroenterology (1999)
AGA technical review on irritable bowel syndrome
Douglas A. Drossman;Michael Camilleri;Emeran A. Mayer;William E. Whitehead.
Gastroenterology (2002)
Clinical Guideline: Management of Gastroparesis
Michael Camilleri;Henry P. Parkman;Mehnaz A. Shafi;Thomas L. Abell.
The American Journal of Gastroenterology (2013)
Current concepts: Chronic constipation
Anthony Lembo;Michael Camilleri.
The New England Journal of Medicine (2003)
Irritable bowel syndrome: A technical review for practice guideline development
DA Drossman;WE Whitehead;M Camilleri.
Gastroenterology (1997)
Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine.
Thomas L. Abell;Michael Camilleri;Kevin Donohoe;William L. Hasler.
Journal of Nuclear Medicine Technology (2008)
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial
Michael Camilleri;Allison R Northcutt;Steven Kong;George E Dukes.
The Lancet (2000)
A placebo-controlled trial of prucalopride for severe chronic constipation.
Michael Camilleri;René Kerstens;An Rykx;Lieve Vandeplassche.
The New England Journal of Medicine (2008)
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.
H. J. Kim;M. Camilleri;S. Mckinzie;M. B. Lempke.
Alimentary Pharmacology & Therapeutics (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mayo Clinic
Mayo Clinic
Mayo Clinic
University of Newcastle Australia
Mayo Clinic
Mayo Clinic
Mayo Clinic
Temple University
KU Leuven
Mayo Clinic
University of Lille
Ghent University
Delft University of Technology
Spanish National Research Council
University of Regensburg
Institut de Chimie des Substances Naturelles
University of Ottawa
Dalhousie University
Federal University of Pernambuco
University of the Basque Country
University of Lübeck
The University of Texas MD Anderson Cancer Center
Stanford University
University of Oxford
University of Washington
University of Michigan–Ann Arbor